BCL11A and Schnyder corneal dystrophy: For example, patients with transfusion-dependent β thalassemia (TDT) and sickle-cell disorder (SCD) caused by reduced levels of y-globulin can be treated by using CRISPR-KO targeted to a transcription factor named BCL11A [46].